https://www.bioworld.com/rss en-us http://www.bioworld.com/articles/730228 Fri, 10 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730228-realta-secures-another-40m-for-its-hypoxic-ischemic-encephalopathy-treatment Photo of hands holding a baby http://www.bioworld.com/articles/729951 Mon, 30 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729951-aad-2026-targeted-oral-therapies-challenge-injected-biologics Oral medication http://www.bioworld.com/articles/730034 Fri, 27 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/730034-pinnacle-raises-an-89m-series-b-for-its-oral-peptide-programs Hand holding dollar sign http://www.bioworld.com/articles/729903 Thu, 26 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729903-pinnacle-raises-an-89m-series-b-for-its-oral-peptide-programs Hand holding dollar sign http://www.bioworld.com/articles/729860 Tue, 24 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/729860-endocyclics-endo-205-gains-ind-clearance-for-endometriosis http://www.bioworld.com/articles/729772 Fri, 20 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/729772-kalohexis-launches-as-spin-out-from-endevica-bio Illustration of human body composed of molecules http://www.bioworld.com/articles/729734 Thu, 19 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/729734-group-in-taiwan-patents-new-peptides-and-lipid-nanoparticles-for-cancer http://www.bioworld.com/articles/729558 Wed, 18 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729558-icotydes-in-wave-of-switchers-to-oral-psoriasis-protagonist Icotyde Credit: Johnson & Johnson http://www.bioworld.com/articles/729549 Tue, 17 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729549-structures-oral-glp-1-data-mark-bullish-year-for-obesity-pills GLP-1 capsule http://www.bioworld.com/articles/729711 Tue, 17 Mar 2026 08:00:00 -0400 https://www.bioworld.com/articles/729711-g2gbio-secures-license-deal-20b-investment-from-samsung-epis G2gbio-Samsung-Bioepis deal signing From left: Epis Nexlab CEO Peter (Seong-won) Hong, Samsung Bioepis CEO Kim Kyung-ah and G2Gbio CEO Lee Hee-yong.  http://www.bioworld.com/articles/729532 Mon, 16 Mar 2026 17:00:00 -0400 https://www.bioworld.com/articles/729532-g2gbio-secures-license-deal-20b-investment-from-samsung-epis G2gbio-Samsung-Bioepis deal signing From left: Epis Nexlab CEO Peter (Seong-won) Hong, Samsung Bioepis CEO Kim Kyung-ah and G2Gbio CEO Lee Hee-yong.  http://www.bioworld.com/articles/729577 Tue, 10 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/729577-synthetic-peptide-and-car-a-each-clear-amyloid-in-alzheimers Illustration of amyloid plaques on neurons Biomedicine & Pharmacotherapy, investigators evaluated the activity of a 7-amino-acid peptide, EB-203, using a zebrafish model of diabetic retinopathy (DR)-like vascular alterations.]]> http://www.bioworld.com/articles/729419 Mon, 09 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/729419-eb-203-improves-diabetic-retinopathy-like-pathology-in-zebrafish Illustration showing cross section of eye with diabetic retinopathy http://www.bioworld.com/articles/729411 Mon, 09 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/729411-synthetic-peptide-and-car-a-each-clear-amyloid-in-alzheimers Illustration of amyloid plaques on neurons http://www.bioworld.com/articles/729355 Fri, 06 Mar 2026 12:00:00 -0500 https://www.bioworld.com/articles/729355-zealand-touts-efficacy-safety-for-petrelintide-phase-ii-obesity-trial Man measuring waist http://www.bioworld.com/articles/729375 Thu, 05 Mar 2026 08:00:00 -0500 https://www.bioworld.com/articles/729375-stapled-peptide-p3lc7lc-p-emerges-as-a-promising-candidate-for-ischemic-stroke Brain and blood cells http://www.bioworld.com/articles/729318 Tue, 03 Mar 2026 12:00:00 -0500 https://www.bioworld.com/articles/729318-jiuyuan-seeks-approval-of-wegovy-biosimilar-in-china http://www.bioworld.com/articles/729271 Mon, 02 Mar 2026 12:00:00 -0500 https://www.bioworld.com/articles/729271-dwarfism-drug-gets-fda-accelerated-approval-for-ascendis FDA-approved-stamp2.png http://www.bioworld.com/articles/729245 Thu, 26 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/729245-jiuyuan-seeks-approval-of-wegovy-biosimilar-in-china http://www.bioworld.com/articles/729200 Wed, 25 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/729200-vivtexs-oral-drug-delivery-approach-draws-novo-in-21b-deal GI-ORIS-pic-Vivtex-2-25.jpg GI-ORIS, or “GI tract on a chip” screening system. Credit: Vivtex Corp. http://www.bioworld.com/articles/729234 Tue, 24 Feb 2026 11:00:00 -0500 https://www.bioworld.com/articles/729234-ascletis-raises-107m-to-advance-oral-glp-1-to-phase-iii-trials 3D dollar sign http://www.bioworld.com/articles/729176 Mon, 23 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/729176-novos-next-gen-obesity-drug-fails-to-beat-lillys-zepbound http://www.bioworld.com/articles/728952 Fri, 20 Feb 2026 08:00:00 -0500 https://www.bioworld.com/articles/728952-animate-studies-mbb32-in-mouse-myocardial-infarction-model 3D heart in chest http://www.bioworld.com/articles/729075 Wed, 18 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/729075-unnatural-products-signs-18b-cardio-pact-with-novartis http://www.bioworld.com/articles/728833 Fri, 13 Feb 2026 08:00:00 -0500 https://www.bioworld.com/articles/728833-cd206-macrophage-targeting-peptide-alleviates-obstructive-renal-fibrosis-in-mice Illustration of diseased kidney http://www.bioworld.com/articles/728847 Thu, 12 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/728847-viking-to-push-oral-glp-1-gip-drug-into-phase-iii-obesity-trial Pills and bottle http://www.bioworld.com/articles/728730 Wed, 11 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/728730-ascletis-raises-107m-to-advance-oral-glp-1-to-phase-iii-trials 3D dollar sign http://www.bioworld.com/articles/728719 Tue, 10 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/728719-us-fda-finds-ad-introducing-wegovy-pill-misleading http://www.bioworld.com/articles/728703 Mon, 09 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/728703-compounded-weight-loss-drugs-hit-on-every-side http://www.bioworld.com/articles/728623 Tue, 03 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/728623-china-nmpa-approves-sciwinds-glp-1-injection-for-diabetes